Study: Data Show Lower Daily Temperatures Lead to Higher Transmission of COVID-19
February 25th 2021SARS-CoV-2 belongs to a family of human coronaviruses, most of which are characterized by increased transmission in cooler, less humid months and decreased transmission in warmer, more humid months.
Read More
Expansion of Opaganib Global Phase 2/3 COVID-19 Study Planned for Patients With Severe COVID-19
February 24th 2021A global phase 2/3 study of opaganib in patients with severe COVID-19 is set to be expanded, following FDA review of the data from the phase 2 study of the drug and RedHill Biopharma’s receipt of its recommendations.
Read More
Study Estimates Financial Impact of COVID-19 as Insurers End Grace Period for Hospital Costs
February 24th 2021The estimate is based on a new analysis of out-of-pocket costs for influenza-related hospitalizations in 2018 that were paid by people with Medicare Advantage plans, which are Medicare plans run by private insurance companies.
Read More
Study: Asthmatics Do Not Have Higher Risk of Death From COVID-19
February 24th 2021Researchers in Australia analyzed data from 57 studies with an overall sample size of 587,280 individuals. Approximately 350,000 people in the pool had been infected with COVID-19 from Asia, Europe, and North and South America.
Read More
Study: Irregular Sleep Conducted to Bad Moods, Depression
February 24th 2021Those whose waking time varies from day to day may find themselves in as much of a foul mood as those who stayed up extra late the night before, or who got up extra early that morning, according to the study authors.
Read More
Study: Differences in Walking Patterns Could Predict Type of Cognitive Decline in Older Adults
February 23rd 2021The study compared step impairments across the cognitive spectrum, including people with subjective cognitive impairment, Parkinson disease, mild cognitive impairment, Alzheimer disease, Lewy body dementia, and frontotemporal dementia, as well as cognitively healthy controls.
Read More
FDA Approves Libtayo as Monotherapy for Advanced Non-Small Cell Lung Cancer
February 23rd 2021This is the third approval for Libtayo, following approvals as the first immunotherapy for patients with advanced basal cell carcinoma and as the first systemic treatment for advanced cutaneous squamous cell carcinoma.
Read More
COVID-19 Pandemic Has Resulted in Fewer Heart Surgeries, More Patient Deaths
February 23rd 2021The COVID-19 pandemic has resulted in a significant decline in the volume of overall heart surgeries, as well as an increase in deaths following coronary artery bypass grafting, according to research.
Read More
Report Cites Addressing Health Disparities to End HIV Epidemic
February 22nd 2021Researchers, advocates, and other stakeholders are urging for care to be expanded to overcome barriers in high-risk populations to address the HIV epidemic, as part of a series published in The Lancet HIV in the USA Series.
Read More